THC Therapeutics, Inc. (THCT) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
11700 W CHARLESTON BLVD #73 LAS VEGAS, NV 89135 |
| State of Incorp. | |
| Fiscal Year End | July 31 |
| Industry (SIC) | 3523 - Farm Machinery and Equipment (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 7/31/2022 | 1/31/2022 TTM | 7/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2013 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 0 | 25 | 296 | 43 | 318 | 15 | ||
| Cash and cash equivalents | 0 | 25 | 296 | 43 | 318 | 15 | ||
| Inventory, net of allowances, customer advances and progress billings | 0 | 1 | 1 | ✕ | ||||
| Inventory | 0 | 1 | 1 | |||||
| Prepaid expense | 41 | 15 | 5 | 140 | 0 | |||
| Other undisclosed current assets | 2 | |||||||
| Total current assets: | 41 | 41 | 302 | 43 | 458 | 18 | ||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | (88) | 3 | 9 | 21 | 37 | |||
| Intangible assets, net (including goodwill) | 13 | 14 | 16 | 21 | 25 | ✕ | ||
| Intangible assets, net (excluding goodwill) | 13 | 14 | 16 | 21 | 25 | |||
| Other undisclosed noncurrent assets | 240 | 153 | 153 | 175 | ||||
| Total noncurrent assets: | 166 | 170 | 179 | 42 | 62 | 175 | ||
| TOTAL ASSETS: | 207 | 211 | 480 | 85 | 520 | 193 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 1,581 | 812 | 485 | 499 | 159 | 65 | ||
| Accrued liabilities | 218 | 65 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 1,581 | 812 | 485 | 499 | (59) | |||
| Debt | 601 | 25 | 8 | |||||
| Derivative instruments and hedges, liabilities | 674 | 1,080 | 153 | 843 | 20 | |||
| Due to related parties | 17 | 597 | 514 | 75 | 104 | |||
| Other undisclosed current liabilities | 345 | 856 | 1,706 | 447 | 982 | 52 | ||
| Total current liabilities: | 3,217 | 3,345 | 2,857 | 1,864 | 1,269 | 146 | ||
| Noncurrent Liabilities | ||||||||
| Total liabilities: | 3,217 | 3,345 | 2,857 | 1,864 | 1,269 | 146 | ||
| Commitments and contingencies | 100 | 100 | 100 | |||||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (3,110) | (3,234) | (2,477) | (1,779) | (749) | 47 | ||
| Common stock | 32 | 32 | 29 | 21 | 14 | 74 | ||
| Additional paid in capital | 41,174 | 40,777 | 40,254 | 39,506 | 38,422 | 1,701 | ||
| Deferred compensation equity | (456) | |||||||
| Accumulated deficit | (38,037) | (37,757) | (36,518) | (34,626) | (32,701) | |||
| Warrants and rights outstanding | 249 | |||||||
| Other undisclosed stockholders' equity attributable to parent | (6,279) | (6,287) | (6,243) | (6,680) | (6,484) | (1,522) | ||
| Total stockholders' equity: | (3,110) | (3,234) | (2,477) | (1,779) | (749) | 47 | ||
| TOTAL LIABILITIES AND EQUITY: | 207 | 211 | 480 | 85 | 520 | 193 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 7/31/2022 | 1/31/2022 TTM | 7/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2013 | ||
|---|---|---|---|---|---|---|---|
| Gross profit: | (277) | ||||||
| Operating expenses | (1,746) | (1,588) | (940) | (1,318) | 26,690 | (365) | |
| Other operating expense, net (Other Expenses) | (768) | ||||||
| Other undisclosed operating income (loss) | (53,380) | 1,046 | |||||
| Operating loss: | (1,746) | (1,588) | (940) | (1,318) | (26,690) | (365) | |
| Nonoperating income | 227 | 11,756 | |||||
| Investment income, nonoperating | 8,373 | ||||||
| Other nonoperating income | 3,383 | ||||||
| Interest and debt expense | (100) | (419) | (552) | (323) | 304 | 2 | |
| Loss from continuing operations before income taxes: | (1,619) | (2,006) | (1,492) | (1,641) | (14,630) | (363) | |
| Income tax expense | (7,973) | (7,669) | (104) | ||||
| Other undisclosed loss from continuing operations | (7,669) | ||||||
| Loss before gain (loss) on sale of properties: | (9,592) | (9,675) | (9,161) | (1,641) | (14,734) | (363) | |
| Other undisclosed net income (loss) | 8,073 | (8,573) | (771) | ||||
| Net loss: | (1,519) | (9,675) | (9,161) | (1,641) | (23,307) | (1,133) | |
| Other undisclosed net income (loss) attributable to parent | 7,001 | 7,275 | (284) | ||||
| Net loss available to common stockholders, diluted: | (1,519) | (2,674) | (1,885) | (1,925) | (23,307) | (1,133) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 7/31/2022 | 1/31/2022 TTM | 7/31/2021 | 7/31/2020 | 7/31/2019 | 7/31/2013 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (1,519) | (9,675) | (9,161) | (1,641) | (23,307) | (1,133) | |
| Comprehensive loss, net of tax, attributable to parent: | (1,519) | (9,675) | (9,161) | (1,641) | (23,307) | (1,133) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.